Recent Finacing
Recent Raise
Surge develops an AI-driven immune-profiling platform that decodes blood-based immune biomarkers to predict surgical complication risk, propose preventive management, and commercialize products (PreCyte) with Stanford-licensed algorithms and clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
